Myriad Genetics Inc (NASDAQ:MYGN)

33.59
Delayed Data
As of Apr 24
 -0.77 / -2.24%
Today’s Change
31.56
Today|||52-Week Range
42.50
-1.38%
Year-to-Date

Today’s Trading

Previous close34.36
Today’s open34.38
Day’s range33.54 - 34.40
Volume418,246
Average volume (3 months)831,546
Market cap$2.4B
Dividend yield--
Data as of 4:00pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-37.28%
Earnings growth (next 5 years)+14.19%
Revenue growth (last year)+26.92%
P/E ratio23.2
Price/Sales3.31
Price/Book3.43

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...+0.23+0.19%
PTCTPTC Therapeutics Inc-0.88-1.23%
LCILannett Company Inc0.000.00%
CBPOChina Biologic Produ...-0.35-0.35%
Data as of 4:01pm ET, 04/24/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)$0.39
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers